Dr Megan Baldwin, PhD – Non-Executive Director Dr Baldwin is Founder and Chief Innovation Officer of Opthea Limited (ASX:OPT; NASDAQ:OPT), a late-stage biopharmaceutical company developing a novel therapy to address the unmet need in the treatment of retinal eye...
Scott Richards – Non-Executive Director Scott Richards brings over 35 years of international experience in the pharmaceutical industry to his current role as Chief Executive Officer of Envision Sciences, a privately held precision medicine company focused on advanced...
Dr Phil Kearney – Chairman, General Advisory Board Dr Kearney holds an MBA from the University of Sydney and completed his PhD genetics at Monash University. He spent a post-doc at Imperial College London mapping the human Y chromosome and later worked on mapping the...
Prof. Marc Achen – General Advisory Board Member Professor Marc Achen is a Laboratory Head at St Vincent’s Institute of Medical Research, Melbourne, and an expert in molecular aspects of vascular biology. He has published over 100 international research papers...
Prof. Peter Koopman – General Advisory Board Member Prof. Koopman is Emeritus Professor at the University of Queensland (UQ), and a Fellow of the Australian Academy of Science. He has over 40 years’ experience in biomedical research, specializing in...
